当前位置: 首页 > 期刊 > 《延边医学》 > 2012年第5期
编号:12280611
甘草有效成分应用与药理作用研究进展(3)
http://www.100md.com 2012年5月1日 《延边医学》 2012年第5期
     [18] WANGY S, XUL, MAK,etal. Protective effectsofGinkgo bilobaextract761 againstglutamate-induced neurotoxicity in cultured retinalneuron[J].ChinMedJ(中华医学杂志), 2005, 118 (11);948-952.

    [19] ABLISEM, LEININGER-MULLER B, DALWONG C,etal. Synthesis andin vitroantioxidant activity of glycyrrhetinic acid derivativestestedwith the Cytochrome P450/NADPH system[J].Chem PharmBull, 2004, 52(12):1436-1439.

    [20] LEBORGNE L, MAZIERE J C, MAZIERE C,et al. Oxidativestress, atherogenesis and cardiovascular risk factors[J].Arch MalCoeurVaiss, 2002, 95(5):805-814.

    [21] 石维福,等.新药与临床,1994,13(2):123.

    [6] 姜小卓,李紫霞.谈谈甘草酸的临床应用价值[J].中外医疗,2009(16):107.

    [22] 陈宇萍,刘新记,刘克锋,等.复方甘草酸苷注射液治疗传染性非典型肺炎的临床观察[J].中国药房,2004,15(5):294-295.

    [23] Wang JY. Polyamines and mRNA stability in regulation of intestinalmucosal growth[J]. AminoAcids. 2007, 33(2):241.

    [24] Zou T, Liu L, Rao JN, et a.l Polyaminesmodulate the subcellular lo-calization ofRNA-binding proteinHuR through AMP-activated pro-tein kinase-regulated phosphorylation and acetylation of importin al-pha1[J]. Biochem J, 2008, 409(2):389.

    [25] 张若松.中药甘草的不良反应和对策研究[J].中国医药导报,2009,6(9):161-162., 百拇医药(谭忠谋)
上一页1 2 3